DSM announces amendment to share repurchase program and reports repurchase of shares (3-9 June 2016)

Heerlen, NL, 10 Jun 2016 09:00 CEST

Royal DSM, a global science-based company active in health, nutrition and materials, today announces that it intends to increase the running share repurchase program as announced on 22 February 2016 by an additional 300,000 ordinary shares to a total of 3,500,000 ordinary shares. The additional shares repurchased will be used to cover the interim stock dividend 2016. Based on the closing price of the DSM share on Euronext Amsterdam on 9 June 2016, this additional repurchase would be equivalent to approximately €17million. Consequently, the total consideration of the repurchase program is now estimated to be approximately €180 million.

The repurchase of the additional shares will take place under the same conditions as the original program as announced on 22 February 2016.The program is anticipated to continue into Q3 2016. The total number of shares to be repurchased under the program represents approximately 1.93% of ordinary shares issued.

In accordance with the program, DSM reports that it has repurchased 139,054 of its own shares in the period from 3 June 2016 up to and including 9 June 2016 at an average price of €56.45. The consideration of this repurchase was €7.9 million.

The total number of shares repurchased under this program to date is 2,725,001 shares for a total consideration €135.8 million.